REFERENCES
S. A. Mousa, J. M. Bozarth, M. S. Forsythe, W. Lorelli, M. J. Thoolen, N. Ramachandran, S. Jackson, W. De Grado, and T. M. Reilly. Antiplatelet Efficacy and Specificity of DMP 728, a Novel Platelet GPIIb/IIIa Receptor Antagonist. Cardiology 83:374–382 (1993).
S. A. Mousa, J. M. Bozarth, M. S. Forsythe, S. M. Jackson, A. Leamy, M. M. Diemer, R. P. Kapil, R. M. Knabb, M. C. Mayo, S. K. Pierce, W. F. De Grado, M. J. Thoolen, and T. M. Reilly. Antiplatelet and Antithrombotic Efficacy of DMP 728, a Novel Platelet GPIIb/IIIa Receptor Antagonist. Circulation 89:3–12 (1994).
S. M. Berge, L. D. Bighley, and D. C. Monkhouse. Pharmaceutical Salts. J. Pharm. Sci. 66:1–19 (1977).
G. C. Mazzenga and B. Berner. The Transdermal Delivery of Zwitterionic Drugs I: The Solubility of Zwitterion Salts. J. Controlled Release 16:77–88 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maurin, M.B., Hussain, M.A. A Novel Isolation Method of a Stable Crystalline Salt of a Cyclic RGD Peptide Zwitterion. Pharm Res 12, 1810–1812 (1995). https://doi.org/10.1023/A:1016250730039
Issue Date:
DOI: https://doi.org/10.1023/A:1016250730039